Insider trade

Hims & Hers Health (HIMS): CFO sold ~$956K

Oluyemi Okupe, CFO at Hims & Hers Health, sold ~$956K of Hims & Hers Health shares.

~$956K
Approx. value · 37K sh @ $25.90
282K
Holds after · shares reported
Traded
Apr 16, 2026
Filed
Apr 20, 2026

What stands out in this filing

  • The sale was 11.6% of the shares this insider held before it; the filing reports 281,867 shares afterwards.
  • 36,922 shares at an average of $25.90 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 19, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  2. Feb 23, 2026Company filing · Form 8-K · ResultsReported its results
  3. Feb 27, 2026InsiderOfficer sold ~$71K of HIMS shares in the open market
  4. Mar 17, 2026Insider · 3 peopleInsiders: 3 sales (~$2.7M)
  5. Mar 20, 2026InsiderCFO sold ~$219K of HIMS shares in the open market
  6. Apr 6, 2026InsiderCFO sold ~$79K of HIMS shares in the open market
  7. Apr 16, 2026 · this disclosureInsiderCFO sold ~$956K of HIMS shares in the open market

What came next

  1. Apr 17, 2026InsiderCFO sold ~$501K of HIMS shares in the open market
  2. Apr 20, 2026Insider · 2 peopleInsiders: 2 sales (~$873K)
  3. May 11, 2026Company filing · Form 8-K · ResultsReported its results
  4. May 18, 2026InsiderCFO sold ~$188K of HIMS shares in the open market
  5. May 21, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  6. May 26, 2026Insider · First insider buy since Nov 2024Director purchased ~$1.17M of HIMS shares in the open market
  7. May 29, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  8. Jun 16, 2026InsiderOfficer sold ~$229K of HIMS shares in the open market
  9. Jun 17, 2026Insider · 3 peopleInsiders: 3 sales (~$1.5M)
  10. Jun 18, 2026InsiderOfficer sold ~$830K of HIMS shares in the open market
  11. Jun 22, 2026InsiderCFO sold ~$619K of HIMS shares in the open market
  12. Jun 26, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  13. Jul 6, 2026InsiderCFO sold ~$261K of HIMS shares in the open market
  14. Jul 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.”
  15. Jul 17, 2026InsiderCFO sold ~$229K of HIMS shares in the open market
  16. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

Other recent filings by Oluyemi Okupe, Chief Financial Officer

The full history of Oluyemi Okupe, Chief Financial Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Hims & Hers Health (HIMS) insider traded, and how much?

Oluyemi Okupe, CFO at Hims & Hers Health, sold ~$956K of Hims & Hers Health shares. 37K shares at $25.90.

When did it happen, and when was it made public?

Traded: Apr 16, 2026. Filed: Apr 20, 2026. That is 4 days between the two dates.

What stands out in this filing?

The sale was 11.6% of the shares this insider held before it; the filing reports 281,867 shares afterwards. 36,922 shares at an average of $25.90 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data